Target intelligence / Profile preview

Heme polymerization machinery

Molecular classification
Metabolic pathway, Biocrystallization process
01

Overview

The heme polymerization machinery is a critical detoxification process within the digestive vacuole of Plasmodium falciparum, the causative agent of malaria. During the intraerythrocytic stage, the parasite ingests and degrades host hemoglobin to obtain essential amino acids, a process that releases large quantities of free heme (ferriprotoporphyrin IX). Because free heme is highly toxic and can cause oxidative damage to membranes and proteins, the parasite converts it into an insoluble, inert crystalline polymer known as hemozoin, or malaria pigment. This biocrystallization is facilitated by specific proteins, such as Heme Detoxification Protein (HDP) and Histidine-Rich Proteins (HRPs), as well as lipid environments within the vacuole (Jani et al., 2008, J Biol Chem; Pisciotta et al., 2007, Biochem J). Many classic antimalarial drugs, particularly the 4-aminoquinolines like chloroquine, exert their therapeutic effect by binding to heme monomers or the growing crystal surface, thereby preventing further polymerization (Slater and Cerami, 1992, Nature). The resulting accumulation of toxic free heme leads to the destruction of the parasite's membranes and eventual cell death (Egan, 2008, Drug Des Devel Ther). This machinery remains one of the most validated and successful targets in antimalarial drug development.

Other names
Hemozoin formation pathwayHeme detoxification pathwayHeme biocrystallizationMalaria pigment formation
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin, resulting in the accumulation of toxic free ferriprotoporphyrin IX which causes oxidative damage and parasite death (Slater and Cerami, 1992, Nature; Egan, 2008, Drug Des Devel Ther).

03

Biological functions

Heme detoxificationHemozoin formationHemoglobin catabolism
04

Disease associations

MalariaInfection
05

Safety considerations

Emergence of drug resistanceRetinal toxicityCardiovascular effects (QT prolongation)
06

Interacting drugs

Chloroquine

6 more in the full profile.

07

Biomarkers

Hemozoin levelsParasite clearance ratePlasmodium falciparum chloroquine resistance transporter (PfCRT) mutations

Beyond the preview

Go deeper on Heme polymerization machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme polymerization machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call